Breast Cancer Clinical Trial

Attitudes Toward Physical Activity and Nutrition Intervention During Cancer Treatment

Summary

Twenty-five women will be followed through their breast cancer treatment. The women will be asked to provide their opinions and desires for lifestyle intervention at different times throughout treatment. In addition, basic clinical data will be collected . The primary goal of this pilot study is to investigate the physical and behavioral changes that occur in patients receiving treatment for breast cancer.

View Full Description

Full Description

In this cross sectional, longitudinal, observational study, 25 women will be followed through their treatment for stage I-III breast cancer. The women will be asked to provide their opinions and desires for lifestyle intervention at four timepoints throughout treatment. In addition to qualitative data, basic clinical data will be collected (anthropometrics, vital signs, dietary intake, and physical activity). The primary goal of this pilot study is to investigate the anthropometric and behavioral changes that occur in patients undergoing adjuvant chemotherapy for breast cancer.

Aim 1: To better understand patients' attitudes toward and perceived barriers to nutrition and physical activity interventions during neoplastic treatment.

Hypothesis: Patients' reported attitudes, motivation, and perceived barriers will change throughout treatment.

Aim 2: To measure the physical and metabolic changes that occur throughout neoplastic treatment for breast cancer.

Hypothesis: Over 50% of the participants will gain body weight during treatment and metabolic parameters will trend with body weight change.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Female
≥18 years of age
Diagnosed with stage I, II or III breast cancer with plans to undergo endocrine and/or chemotherapy treatment (radiation in combination with one or more of these therapies is acceptable)
Willing to complete up to 4 clinic visits

Exclusion Criteria:

Have received neoadjuvant therapy for current diagnosis
Currently receiving adjuvant chemotherapy or other adjuvant therapy that was initiated prior to study enrollment
History of cancer and neoplastic treatment

Study is for people with:

Breast Cancer

Estimated Enrollment:

10

Study ID:

NCT02887196

Recruitment Status:

Terminated

Sponsor:

Pennington Biomedical Research Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Pennington Biomedical Research Center
Baton Rouge Louisiana, 70808, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

10

Study ID:

NCT02887196

Recruitment Status:

Terminated

Sponsor:


Pennington Biomedical Research Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider